GEA
IOVA icon

Glen Eagle Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Glen Eagle Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$3.29K – 995
2020
Q3 		$3.29K Hold
100
– – ﹤0.01% 744
2020
Q2 		$2.75K Hold
100
– – ﹤0.01% 733
2020
Q1 		$2.99K Hold
100
– – ﹤0.01% 683
2019
Q4 		$2.77K Hold
100
– – ﹤0.01% 760
2019
Q3 		$1.82K Hold
100
– – ﹤0.01% 715
2019
Q2 		$2.45K Buy
+100
New +$1.51K ﹤0.01% 679

Other funds holding IOVA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return